<- Go Home
Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.
Market Cap
SEK 7.3B
Volume
108.6K
Cash and Equivalents
SEK 659.2M
EBITDA
SEK 188.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 577.5M
Profit Margin
68.59%
52 Week High
SEK 251.60
52 Week Low
SEK 118.80
Dividend
N/A
Price / Book Value
1.60
Price / Earnings
35.24
Price / Tangible Book Value
9.53
Enterprise Value
SEK 6.7B
Enterprise Value / EBITDA
32.68
Operating Income
SEK 164.4M
Return on Equity
4.70%
Return on Assets
2.13
Cash and Short Term Investments
SEK 659.2M
Debt
N/A
Equity
SEK 4.6B
Revenue
SEK 842.0M
Unlevered FCF
SEK 60.0M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium